The type III histone deacetylase Sirt1 protein suppresses p300-mediated histone H3 lysine 56 acetylation at Bclaf1 promoter to inhibit T cell activation
about
Potential Modulation of Sirtuins by Oxidative StressRedox regulation of SIRT1 in inflammation and cellular senescenceSirtuins in epigenetic regulationIcariin induces synoviolin expression through NFE2L1 to protect neurons from ER stress-induced apoptosisAuto-acetylation stabilizes p300 in cardiac myocytes during acute oxidative stress, promoting STAT3 accumulation and cell survivalAnalysis of sirtuin 1 expression reveals a molecular explanation of IL-2-mediated reversal of T-cell toleranceThe class III histone deacetylase sirtuin 1 in immune suppression and its therapeutic potential in rheumatoid arthritis.Sirtuin 1 facilitates chemoresistance of pancreatic cancer cells by regulating adaptive response to chemotherapy-induced stressc-Abl-mediated tyrosine phosphorylation of the T-bet DNA-binding domain regulates CD4+ T-cell differentiation and allergic lung inflammationHistone deacetylase inhibitors globally enhance h3/h4 tail acetylation without affecting h3 lysine 56 acetylation.Pygo2 regulates histone gene expression and H3 K56 acetylation in human mammary epithelial cells.The Histone Deacetylase Sirtuin 1 Is Reduced in Systemic Sclerosis and Abrogates Fibrotic Responses by Targeting Transforming Growth Factor β Signaling.A Novel Combinatorial Epigenetic Therapy Using Resveratrol and Pterostilbene for Restoring Estrogen Receptor-α (ERα) Expression in ERα-Negative Breast Cancer Cells.The Commercial Antibodies Widely Used to Measure H3 K56 Acetylation Are Non-Specific in Human and Drosophila Cells.Ligand-activated peroxisome proliferator-activated receptor-δ and -γ inhibit lipopolysaccharide-primed release of high mobility group box 1 through upregulation of SIRT1SIRT1 is involved in oncogenic signaling mediated by GPER in breast cancer.The presence of HIV-1 Tat protein second exon delays fas protein-mediated apoptosis in CD4+ T lymphocytes: a potential mechanism for persistent viral productionBclaf1 is an important NF-κB signaling transducer and C/EBPβ regulator in DNA damage-induced senescence.Myeloid deletion of SIRT1 suppresses collagen-induced arthritis in mice by modulating dendritic cell maturation.The Roles of SIRT1 in Cancer.The apoptotic effects of sirtuin1 inhibitor on the MCF-7 and MRC-5 cell lines.A dietary regimen of caloric restriction or pharmacological activation of SIRT1 to delay the onset of neurodegenerationResveratrol improves salivary dysfunction in a non-obese diabetic (NOD) mouse model of Sjögren's syndrome.Histone deacetylase sirtuin 1 deacetylates IRF1 protein and programs dendritic cells to control Th17 protein differentiation during autoimmune inflammationAnticancer Effects of a New SIRT Inhibitor, MHY2256, against Human Breast Cancer MCF-7 Cells via Regulation of MDM2-p53 Binding.Sirtuin 1 (SIRT1): the misunderstood HDAC.Sirtuin 1 in immune regulation and autoimmunity.Anticancer agents targeted to sirtuins.BCLAF1 and its splicing regulator SRSF10 regulate the tumorigenic potential of colon cancer cells.DYRK1A phoshorylates histone H3 to differentially regulate the binding of HP1 isoforms and antagonize HP1-mediated transcriptional repression.Intercellular interplay between Sirt1 signalling and cell metabolism in immune cell biology.Histone chaperone ASF1 is involved in gene transcription activation in response to heat stress in Arabidopsis thaliana.Sirt1 interaction with active Smad2 modulates transforming growth factor-β regulated transcription.Sirtuin 1-Chromatin-Binding Dynamics Points to a Common Mechanism Regulating Inflammatory Targets in SIV Infection and in the Aging Brain.Mammalian target of rapamycin complex 2 (mTORC2) controls glycolytic gene expression by regulating Histone H3 Lysine 56 acetylation.Narrower insight to SIRT1 role in cancer: A potential therapeutic target to control epithelial-mesenchymal transition in cancer cells.The Histone Acetyltransferase Gcn5 Positively Regulates T Cell Activation.Src-mediated phosphorylation converts FHL1 from tumor suppressor to tumor promoter.The Lysine Acetyltransferase GCN5 Is Required for iNKT Cell Development through EGR2 Acetylation.JAK1-mediated Sirt1 phosphorylation functions as a negative feedback of the JAK1-STAT3 pathway.
P2860
Q26770803-FB6D1D99-9A70-4C5B-BE50-CCB9DB04652BQ27023972-ABF49765-A78C-4CA6-B3F5-DE1BB77839E3Q27026861-2FEB6F74-FD73-4F16-8FCF-CEC26A4D4FD2Q28545002-E645E5C1-A741-4819-A6B7-3E2CC2979ACFQ28577251-F0AE2281-E694-4FE4-9113-3742F8A3DCD5Q30504684-79157D57-11C6-4CAF-B463-9D9AACA8F132Q33554869-D8C6A8B1-C2A8-45AB-85D4-B77B7907BAB7Q35051423-05AE6063-3BB7-4888-8DBF-8415904D4B93Q35139941-DC1ED62C-9AF6-40E8-9CDA-B56D8A92FA9DQ35667942-57652AC0-B3E3-4B58-A61D-C09B755B701EQ35737442-7E350302-7BE4-482A-ACCE-5D4076088682Q35899944-F5DA477F-3B51-4224-8AB8-673673896BC6Q36012225-23A08593-EC62-4F1F-8825-4C356609A8DBQ36019938-7972BEF6-C10D-4BF2-8E2D-557A81BEE682Q36291125-028A9BEB-858C-434A-8A82-E1A108D170A9Q36293908-81EE9196-DAB7-44DA-BE2B-8035C5AD250BQ36685165-3323E9F3-2CC4-49B5-B5EF-7557A27382C2Q36799307-8222D393-29A8-4FCC-9D59-22654F3B178CQ36968028-1D9F5735-3CCB-410C-8300-5800593E7483Q37150510-939FBDF3-DB46-42F0-99DD-26D10F3D736FQ37150846-ECD32ED0-FC45-40D9-9FCC-69C41901EFE4Q37178403-19142D63-5C9A-4E87-914D-B94D500D2699Q37247050-841F8012-F616-4751-85B1-BC3EE5D7FBDEQ37415675-DF3160B3-E84C-45B8-81FA-97B3A889ED8EQ37513949-02BA5DB3-8D1F-4B52-8110-2CBF82FF9658Q37956584-B4702548-1351-4A13-9602-8C6B49B5A446Q37959305-220D0F65-B3E4-47DA-A418-989925BFE6B3Q38285137-8B24531F-28C0-436D-A70D-3D03A778D2DAQ38305268-A187F67B-E55C-4DA2-9DAE-81662DEB1D1AQ38307139-103EB563-B57E-457E-898F-F64597A3689EQ38428350-BB291AC5-417C-4E8B-97D2-1345E6D7C573Q42454383-31EECB50-5C88-4AD1-933F-2D71CC5C489FQ47137087-C1AD4245-5C54-467F-8901-B6637A8838DFQ47245579-C2867922-C3B6-4571-A79B-BF880866170AQ47795010-01FF78BF-43CF-4FF4-8C13-60927D3840C7Q48197662-6836EFFF-6FC8-4AF6-9B27-9FC6D064C219Q48257104-171FA8D0-B7E9-4D53-A43A-4EA90BF37C40Q50046229-93493460-4959-47C6-B8DE-264EDB9A9CA9Q50882135-4963B04B-7173-4A60-9026-07F66B8A33C3Q54978493-0E92C54C-F25D-4A7A-AA35-739C171379DD
P2860
The type III histone deacetylase Sirt1 protein suppresses p300-mediated histone H3 lysine 56 acetylation at Bclaf1 promoter to inhibit T cell activation
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
The type III histone deacetyla ...... r to inhibit T cell activation
@ast
The type III histone deacetyla ...... r to inhibit T cell activation
@en
The type III histone deacetyla ...... r to inhibit T cell activation
@nl
type
label
The type III histone deacetyla ...... r to inhibit T cell activation
@ast
The type III histone deacetyla ...... r to inhibit T cell activation
@en
The type III histone deacetyla ...... r to inhibit T cell activation
@nl
prefLabel
The type III histone deacetyla ...... r to inhibit T cell activation
@ast
The type III histone deacetyla ...... r to inhibit T cell activation
@en
The type III histone deacetyla ...... r to inhibit T cell activation
@nl
P2093
P2860
P356
P1476
The type III histone deacetyla ...... r to inhibit T cell activation
@en
P2093
Barry Sandal
Beixue Gao
Donna D Zhang
Sang-Myeong Lee
Seung-Jae Kim
Sinyi Kong
P2860
P304
16967-16975
P356
10.1074/JBC.M111.218206
P407
P577
2011-03-22T00:00:00Z